Payette PJ - Search Results

1

Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.

Payette PJ, Ma X, Weeratna RD, McCluskie MJ, Shapiro M, Engle RE, Davis HL, Purcell RH. Payette PJ, et al. Intervirology. 2006;49(3):144-51. doi: 10.1159/000089375. Intervirology. 2006. PMID: 16428890

2

Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.

McCluskie MJ, Weeratna RD, Payette PJ, Davis HL. McCluskie MJ, et al. Among authors: payette pj. FEMS Immunol Med Microbiol. 2002 Feb 18;32(3):179-85. doi: 10.1111/j.1574-695X.2002.tb00551.x. FEMS Immunol Med Microbiol. 2002. PMID: 11934561 Free article.

3

DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice.

Ma X, Forns X, Gutierrez R, Mushahwar IK, Wu T, Payette PJ, Bukh J, Purcell RH, Davis HL. Ma X, et al. Among authors: payette pj. Vaccine. 2002 Sep 10;20(27-28):3263-71. doi: 10.1016/s0264-410x(02)00304-3. Vaccine. 2002. PMID: 12213395

4

The use of CpG DNA as a mucosal vaccine adjuvant.

McCluskie MJ, Weeratna RD, Payette PJ, Davis HL. McCluskie MJ, et al. Among authors: payette pj. Curr Opin Investig Drugs. 2001 Jan;2(1):35-9. Curr Opin Investig Drugs. 2001. PMID: 11527008 Review.

5

The potential of CpG oligodeoxynucleotides as mucosal adjuvants.

McCluskie MJ, Weeratna RD, Payette PJ, Davis HL. McCluskie MJ, et al. Among authors: payette pj. Crit Rev Immunol. 2001;21(1-3):103-20. Crit Rev Immunol. 2001. PMID: 11642598 Review.

6

History of vaccines and positioning of current trends.

Payette PJ, Davis HL. Payette PJ, et al. Curr Drug Targets Infect Disord. 2001 Nov;1(3):241-7. doi: 10.2174/1568005014606017. Curr Drug Targets Infect Disord. 2001. PMID: 12455398

7

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.

Vollmer J, Weeratna R, Payette P, Jurk M, Schetter C, Laucht M, Wader T, Tluk S, Liu M, Davis HL, Krieg AM. Vollmer J, et al. Eur J Immunol. 2004 Jan;34(1):251-62. doi: 10.1002/eji.200324032. Eur J Immunol. 2004. PMID: 14971051 Free article.

8

Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.

Vollmer J, Weeratna RD, Jurk M, Samulowitz U, McCluskie MJ, Payette P, Davis HL, Schetter C, Krieg AM. Vollmer J, et al. Immunology. 2004 Oct;113(2):212-23. doi: 10.1111/j.1365-2567.2004.01962.x. Immunology. 2004. PMID: 15379982 Free PMC article.

9

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.

Forns X, Payette PJ, Ma X, Satterfield W, Eder G, Mushahwar IK, Govindarajan S, Davis HL, Emerson SU, Purcell RH, Bukh J. Forns X, et al. Among authors: payette pj. Hepatology. 2000 Sep;32(3):618-25. doi: 10.1053/jhep.2000.9877. Hepatology. 2000. PMID: 10960458

10

Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms.

Payette PJ, Weeratna RD, McCluskie MJ, Davis HL. Payette PJ, et al. Gene Ther. 2001 Sep;8(18):1395-400. doi: 10.1038/sj.gt.3301534. Gene Ther. 2001. PMID: 11571579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters